The Benefits of Using Ananda CBD to Help Control Diabetes
CBD, or cannabidiol, has shown potential benefits in helping control diabetes. While more research is needed to understand the effects of CBD on diabetes in humans fully, studies conducted on animals have provided promising results. Here are some potential benefits of using Ananda CBD to help control diabetes:
- Blood Sugar Regulation: CBD has been found to cut down hyperglycemia, or high blood sugar levels, in animal studies. This suggests that CBD may help regulate blood sugar levels in individuals with diabetes.
- Lowered Cholesterol and “Bad Fat” Levels: Animal studies have shown that CBD can lower cholesterol and levels of “bad fat”. This is important for individuals with diabetes, as they are at a higher risk of developing cardiovascular complications.
- Increased Insulin Production: CBD has been found to increase insulin secretion in animal studies. Insulin is a hormone that helps regulate blood sugar levels, and individuals with diabetes often have impaired insulin production or function.
- Reduced Inflammation and Nerve Pain: CBD has been shown to ease swelling and pain from nerve damage in animal studies. This is particularly relevant for individuals with diabetes who may experience neuropathic pain.
It is important to note that most studies on the effects of CBD on diabetes have been conducted on animals, and more research is needed to determine the efficacy and safety of CBD in humans. Additionally, it is always recommended to consult with a healthcare professional before incorporating CBD into your diabetes management plan.
While the research is ongoing, the potential benefits of using Ananda CBD to help control diabetes are promising. CBD may help regulate blood sugar levels, lower cholesterol and “bad fat” levels, increase insulin production, and reduce inflammation and nerve pain. However, further studies are needed to understand the effects of CBD on diabetes in humans fully.
The diabetes problem is enormous in its scope, with approximately 375 million patients worldwide and more than 550 million forecast by 2030. China alone now has 114 million diabetes patients and 200-300 million pre-diabetics (the medical stage immediately preceding diabetes in which blood sugar levels are abnormally high). Approximately 4 million people die each year from it. Diabetes represented at least $465 billion in global healthcare expenditures in 2011. Insulin injections are the principal way in which diabetes is maintained, but many patients remain infirm or are dying due to the inappropriateness of insulin for tactical and economic reasons. There exists an enormous unmet demand for cost-effective oral medicines able to control diabetes, and cannabinoids appear well-suited for this purpose.
ANANDA Scientific has unique, intellectual property regarding cannabidiol (CBD)-based diabetes therapy and is pursuing professionally-refereed, science-based clinical work for bringing what it considers an improved and essential way to control diabetes into the medical marketplace. CBD may even help prevent diabetes